Yen Shen Lu,
Dr. Yen-Shen Lu is currently Clinical Professor of Medicine at the National Taiwan University College of Medicine, as well as Division Chief of Medical Oncology at Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
Dr. Lu graduated from the Chinese Medical College, Taichung, Taiwan in 1992 and obtained his PhD from the National Taiwan University, Taipei, Taiwan in 2006. Dr. Lu has extensive experience as a translational researcher, clinical trial initiator, protocol writer, and as a principal investigator or co-investigator for more than 120 clinical trials. He was the co-chair of steering committee of MONALEESA-7 trial, and chair of steering committee of BYOND and RIGHT Choice trials. He is also the chair of the Asian Breast Cancer Cooperative Group.
He has received the Scholar-in-Training Award at the 92nd Annual Meeting of the American Association Cancer Research in 2001, Chien-Tien Hsu’s Outstanding Cancer Research Award in 2019, the Ministry of Science and Technology Outstanding Research Award in 2020, and the National Taiwan University Hospital Outstanding Research Award in 2020. Dr. Lu has led studies on new drug developments of breast cancer and a series of studies on young female breast cancer, focusing on the epidemiology, biology, and genetic differences between East and Western diagnoses.